Loading clinical trials...
Loading clinical trials...
A Pragmatic Randomized Controlled Trial Study Protocol: XR2ESILIENCE - PIONEERING XR TECHNOLOGY FOR THE PROMOTION OF RESILIENCE AND MENTAL HEALTH OF THE HEALTHCARE WORKFORCE
Conditions
Interventions
XR-based Resilience Training
Waitlist Control
Locations
8
Austria
Medical University of Graz, Clinical Division of Psychiatry and Psychotherapeutic Medicine
Graz, Styria, Austria
Klinika za psihijatriju Sveti Ivan
Zagreb, Croatia
University Medical Center of Johannes Gutenberg University Mainz
Mainz, Rhineland-Palatinate, Germany
Hospital José Joaquim Fernandes
Beja, Beja District, Portugal
Del Henares University Hospital
Coslada, Madrid, Spain
Summa 112
Madrid, Madrid, Spain
Start Date
September 1, 2026
Primary Completion Date
March 1, 2028
Completion Date
March 1, 2028
Last Updated
April 22, 2026
NCT07073963
NCT06805682
NCT07509853
NCT07512869
NCT06623682
NCT07473505
Nina Dalkner Research Prof. Priv.-Doz. Mag. rer.nat. Dr. rer.nat.
CONTACT
+43 316 385 30081nina.dalkner@medunigraz.atLead Sponsor
Medical University of Graz
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions